95 related articles for article (PubMed ID: 17704346)
1. Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes.
Malecki MT; Undas A; Cyganek K; Mirkiewicz-Sieradzka B; Wolkow P; Osmenda G; Walus-Miarka M; Guzik TJ; Sieradzki J
Diabetes Care; 2007 Nov; 30(11):2899-901. PubMed ID: 17704346
[No Abstract] [Full Text] [Related]
2. Plasma apelin and asymmetric dimethylarginine levels in type 2 diabetic patients with diabetic retinopathy.
Yonem A; Duran C; Unal M; Ipcioglu OM; Ozcan O
Diabetes Res Clin Pract; 2009 Jun; 84(3):219-23. PubMed ID: 19344973
[TBL] [Abstract][Full Text] [Related]
3. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
Oğuz A; Uzunlulu M; Yorulmaz E; Yalçin Y; Hekim N; Fici F
Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
[TBL] [Abstract][Full Text] [Related]
4. Diabetic retinopathy is associated with elevated serum asymmetric and symmetric dimethylarginines.
Abhary S; Kasmeridis N; Burdon KP; Kuot A; Whiting MJ; Yew WP; Petrovsky N; Craig JE
Diabetes Care; 2009 Nov; 32(11):2084-6. PubMed ID: 19675197
[TBL] [Abstract][Full Text] [Related]
5. Plasma asymmetric dimethylarginine and retinal vessel diameters in middle-aged men.
Hemminki V; Laakso J; Kähönen M; Turjanmaa V; Uusitalo H; Lehtimäki T; Ruokonen I; Laaksonen R; Huhtala H; Päivä H
Metabolism; 2007 Oct; 56(10):1305-10. PubMed ID: 17884437
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
Krzyzanowska K; Mittermayer F; Krugluger W; Schnack C; Hofer M; Wolzt M; Schernthaner G
Atherosclerosis; 2006 Nov; 189(1):236-40. PubMed ID: 16414052
[TBL] [Abstract][Full Text] [Related]
7. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
[TBL] [Abstract][Full Text] [Related]
8. Increased asymmetric dimethylarginine serum levels are associated with acute rejection in kidney transplant recipients.
Esposito C; Grosjean F; Torreggiani M; Maggi N; Esposito V; Migotto C; Mangione F; Tinelli C; Dal Canton A
Transplant Proc; 2009 Jun; 41(5):1570-3. PubMed ID: 19545681
[TBL] [Abstract][Full Text] [Related]
9. [Multivariate analysis for the understanding of typical diabetic hemostasis criteria. 1: Plasma markers].
Syrbe G; Schröder H; Keil E; Jütte A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(5):717-23. PubMed ID: 1709905
[TBL] [Abstract][Full Text] [Related]
10. [Asymmetric dimethylarginine: metabolism, arginine paradox, pathophysiology].
Gilinskiĭ MA
Usp Fiziol Nauk; 2007; 38(3):21-39. PubMed ID: 17977229
[TBL] [Abstract][Full Text] [Related]
11. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
[TBL] [Abstract][Full Text] [Related]
12. Dimethylarginine dimethylaminohydrolase (DDAH)--a critical regulator of hypertensive left ventricular hypertrophy?
Bai Y; Hui R
Med Hypotheses; 2008; 70(5):962-6. PubMed ID: 17983707
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.
Abbasi F; Asagmi T; Cooke JP; Lamendola C; McLaughlin T; Reaven GM; Stuehlinger M; Tsao PS
Am J Cardiol; 2001 Nov; 88(10):1201-3. PubMed ID: 11703973
[No Abstract] [Full Text] [Related]
14. Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction.
Masuda H
Int J Urol; 2008 Feb; 15(2):128-34. PubMed ID: 18269446
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.
Santilli F; Bucciarelli L; Noto D; Cefalù AB; Davì V; Ferrante E; Pettinella C; Averna MR; Ciabattoni G; Davì G
Free Radic Biol Med; 2007 Nov; 43(9):1255-62. PubMed ID: 17893038
[TBL] [Abstract][Full Text] [Related]
16. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy is associated with increased mean platelet volume in type 2 diabetic patients.
Papanas N; Mavridis G; Karavageli E; Symeonidis G; Maltezos E
Platelets; 2005 Dec; 16(8):498-9. PubMed ID: 16287617
[No Abstract] [Full Text] [Related]
18. [Asymmetrical methylarginine (ADMA) as a cardiovascular risk factor: epidemiological and prospective data].
Böger RH
Dtsch Med Wochenschr; 2004 Apr; 129(15):820-4. PubMed ID: 15054688
[No Abstract] [Full Text] [Related]
19. Is asymmetric dimethylarginine a novel marker of atherosclerosis?
Böger RH; Bode-Böger SM; Matsuoka H; Miyazaki H; Usui M; Ueda S; Okuda S; Imaizumi T; Cooke JP
Circulation; 2000 Apr; 101(14):E160-1. PubMed ID: 10758065
[No Abstract] [Full Text] [Related]
20. Synergistic association of metabolic syndrome and overt nephropathy with elevated asymmetric dimethylarginine in serum and impaired cutaneous microvasodilation in patients with type 2 diabetes.
Yamamoto R; Aso Y
Diabetes Care; 2006 Apr; 29(4):928-30. PubMed ID: 16567841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
